# Duloxetine Tibial Plateau

> **NCT04639011** · PHASE4 · WITHDRAWN · sponsor: **Boston Medical Center**

## Conditions studied

- Tibial Plateau Fracture
- Pain, Postoperative

## Interventions

- **DRUG:** Duloxetine
- **OTHER:** Placebo
- **OTHER:** Standard of care (SOC) for tibial plateau surgery

## Key facts

- **NCT ID:** NCT04639011
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not conducted because funding was not obtained.
- **Last updated:** 2022-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04639011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04639011, "Duloxetine Tibial Plateau". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04639011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*